Clinical Trial Update: A Phase I Study of Zalypsis (PM00104) in Subjects With Advanced Malignant Solid Tumors or Lymphoma [Phase 1]

View source ↗

Summary

Phase I study of Zalypsis (PM00104) in advanced malignant solid tumors or lymphoma; the trial status is terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• Solid Tumors

Drugs mentioned

• Zalypsis (PM00104)

Snippet

Sponsor: PharmaMar | Conditions: Solid Tumors, Lymphoma | Phase 1 | Status: TERMINATED | Results posted: 2021-07-28